NYSE:TMOLife Sciences
Thermo Fisher Resets Footprint With Franklin Closure And US$9b Clario Deal
Thermo Fisher Scientific (NYSE:TMO) is closing its Franklin, Massachusetts facility and winding down operations, with significant job reductions as part of a broader restructuring.
The company has agreed to acquire clinical trial and digital data specialist Clario for about $9 billion in cash.
These moves reshape Thermo Fisher’s operational footprint and expand its reach in clinical research and digital health solutions.
For investors watching NYSE:TMO, these announcements come at a time of...